Screening quality for Ca2+-activated potassium channel in IonWorks Quattro is greatly improved by using BAPTA-AM and ionomycin
Copyright © 2012 Elsevier Inc. All rights reserved..
INTRODUCTION: IonWorks automated patch clamp systems are being widely used for ion channel drug discovery, but the perforated patch mode of these systems makes it difficult to obtain a steady intracellular Ca(2+) concentration ([Ca(2+)](i)). This difficulty prevents obtaining high-quality data regarding Ca(2+)-activated channels such as BK and SK channels. We examined the methods for stabilizing [Ca(2+)](i) in the IonWorks Quattro automated patch clamp system to evaluate BK channels.
METHODS: Electrophysiological recordings were performed using the single-hole or population patch clamp mode of IonWorks Quattro. To increase [Ca(2+)](i), ionomycin was used. The variation in the BK current and the effect of BK channel modulators were examined in the presence and absence of an intracellular Ca(2+) chelator, BAPTA-AM (20μM).
RESULTS: BK current activated by step pulses to +100mV in the presence of ionomycin exhibited large variation (ranging from 0.086 to 11nA). In individual cells, oscillation of the current amplitude was observed when five repetitive pulses were applied at 0.1Hz. Approximately 30% of cells exhibited current variation exceeding 20% when the variation was calculated using the first and third pulses. However, BAPTA-AM treatment before current measurement decreased the number of cells displaying large variation (>20%) to 5%. In the presence of BAPTA-AM, the BK channel modulators NS1619 and 12,14-dichlorodehydroabietic acid increased the BK current at concentrations of 10μM or more showing clear concentration dependency, whereas in its absence, the effect of both compounds was detected only at 30μM.
DISCUSSION: The main finding of this study is that the [Ca(2+)](i) variation in the basal condition is very large and hinders the accurate evaluation of compounds in Ca(2+)-activated ion channels. The application of BAPTA-AM and ionomycin greatly improved the precision of BK channel screening, and this method should be applicable to other Ca(2+)-activated ion channels such as SK channels.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
|---|---|
| Enthalten in: |
Journal of pharmacological and toxicological methods - 67(2013), 1 vom: 01. Jan., Seite 16-24 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ido, Katsutoshi [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 21.10.2013 Date Revised 21.11.2013 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.vascn.2012.10.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM222488743 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM222488743 | ||
| 003 | DE-627 | ||
| 005 | 20231224054407.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.vascn.2012.10.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0741.xml |
| 035 | |a (DE-627)NLM222488743 | ||
| 035 | |a (NLM)23138150 | ||
| 035 | |a (PII)S1056-8719(12)00281-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ido, Katsutoshi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Screening quality for Ca2+-activated potassium channel in IonWorks Quattro is greatly improved by using BAPTA-AM and ionomycin |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.10.2013 | ||
| 500 | |a Date Revised 21.11.2013 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2012 Elsevier Inc. All rights reserved. | ||
| 520 | |a INTRODUCTION: IonWorks automated patch clamp systems are being widely used for ion channel drug discovery, but the perforated patch mode of these systems makes it difficult to obtain a steady intracellular Ca(2+) concentration ([Ca(2+)](i)). This difficulty prevents obtaining high-quality data regarding Ca(2+)-activated channels such as BK and SK channels. We examined the methods for stabilizing [Ca(2+)](i) in the IonWorks Quattro automated patch clamp system to evaluate BK channels | ||
| 520 | |a METHODS: Electrophysiological recordings were performed using the single-hole or population patch clamp mode of IonWorks Quattro. To increase [Ca(2+)](i), ionomycin was used. The variation in the BK current and the effect of BK channel modulators were examined in the presence and absence of an intracellular Ca(2+) chelator, BAPTA-AM (20μM) | ||
| 520 | |a RESULTS: BK current activated by step pulses to +100mV in the presence of ionomycin exhibited large variation (ranging from 0.086 to 11nA). In individual cells, oscillation of the current amplitude was observed when five repetitive pulses were applied at 0.1Hz. Approximately 30% of cells exhibited current variation exceeding 20% when the variation was calculated using the first and third pulses. However, BAPTA-AM treatment before current measurement decreased the number of cells displaying large variation (>20%) to 5%. In the presence of BAPTA-AM, the BK channel modulators NS1619 and 12,14-dichlorodehydroabietic acid increased the BK current at concentrations of 10μM or more showing clear concentration dependency, whereas in its absence, the effect of both compounds was detected only at 30μM | ||
| 520 | |a DISCUSSION: The main finding of this study is that the [Ca(2+)](i) variation in the basal condition is very large and hinders the accurate evaluation of compounds in Ca(2+)-activated ion channels. The application of BAPTA-AM and ionomycin greatly improved the precision of BK channel screening, and this method should be applicable to other Ca(2+)-activated ion channels such as SK channels | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Calcium Ionophores |2 NLM | |
| 650 | 7 | |a Chelating Agents |2 NLM | |
| 650 | 7 | |a Large-Conductance Calcium-Activated Potassium Channels |2 NLM | |
| 650 | 7 | |a 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester |2 NLM | |
| 650 | 7 | |a 139890-68-9 |2 NLM | |
| 650 | 7 | |a Egtazic Acid |2 NLM | |
| 650 | 7 | |a 526U7A2651 |2 NLM | |
| 650 | 7 | |a Ionomycin |2 NLM | |
| 650 | 7 | |a 56092-81-0 |2 NLM | |
| 700 | 1 | |a Ohwada, Tomohiko |e verfasserin |4 aut | |
| 700 | 1 | |a Yasutomi, Eriko |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshinaga, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Arai, Tohru |e verfasserin |4 aut | |
| 700 | 1 | |a Kato, Mitsuyasu |e verfasserin |4 aut | |
| 700 | 1 | |a Sawada, Kohei |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of pharmacological and toxicological methods |d 1996 |g 67(2013), 1 vom: 01. Jan., Seite 16-24 |w (DE-627)NLM012777080 |x 1873-488X |7 nnns |
| 773 | 1 | 8 | |g volume:67 |g year:2013 |g number:1 |g day:01 |g month:01 |g pages:16-24 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.vascn.2012.10.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 67 |j 2013 |e 1 |b 01 |c 01 |h 16-24 | ||